Transactions accelerate innovation for payer clients

交易加速支付方客户的创新

ARNOLD, Md. and MIAMI

马里兰州阿诺德和迈阿密

,

，

Aug. 6, 2026

2026年8月6日

/PRNewswire/ -- ClaimsBridge, a leading provider of end-to-end claim and network technology solutions for TPAs, networks and employers, today announced two milestones in its growth strategy: a strategic investment from Eir Partners Capital (Eir), a private equity firm focused on healthcare technology and tech-enabled services, and the acquisition of DialysisPPO, a company specializing in cost containment for End-Stage Renal Disease (ESRD) and chronic dialysis treatment..

/美通社/ -- ClaimsBridge 是一家为第三方管理机构（TPA）、医疗网络和雇主提供端到端理赔及网络技术解决方案的领先提供商，今日宣布在其增长战略中取得两项里程碑式进展：获得专注于医疗科技和技术赋能服务的私募股权公司 Eir Partners Capital（Eir）的战略投资，并收购专注于终末期肾病（ESRD）和慢性透析治疗成本管控的公司 DialysisPPO。

Together, the moves position ClaimsBridge to accelerate innovation for the self-funded and broader healthcare payer market while adding a specialized, patented solution for one of the fastest-growing and most expensive categories of medical spend.

这些举措共同助力 ClaimsBridge 加速面向自保雇主及更广泛的健康险支付方市场的创新，同时为增长最快、成本最高的医疗支出类别之一提供一项专业化的专利解决方案。

Eir's investment builds on ClaimsBridge's strong foundation, bringing capital and a proven track record of building healthcare technology platforms. ClaimsBridge garners both savings and efficiencies, with their AI enhanced Celerity engine that offers a single vendor pre-adjudication claim workflow.

Eir 的投资建立在 ClaimsBridge 的坚实基础之上，为其带来资金以及在构建医疗健康技术平台方面经过验证的成功记录。ClaimsBridge 凭借其 AI 增强的 Celerity 引擎，实现了成本节约和效率提升，该引擎提供单一供应商的预理赔审核工作流。

Operationally, nothing changes for clients: the same team, processes, and standards of excellence in service remain in place..

在运营层面，客户不受任何影响：同样的团队、流程以及卓越的服务标准将继续保持不变。

Alongside the investment, ClaimsBridge has acquired DialysisPPO. Founded in 2006, DialysisPPO has helped payers save more than $325M through a patented program that allows plans to capture Medicare savings on dialysis claims immediately, without waiting for the thirty-month coordination period typically required.

在此次投资的同时，ClaimsBridge 收购了 DialysisPPO。DialysisPPO 成立于 2006 年，通过一项获得专利的计划，帮助支付方节省了超过 3.25 亿美元。该计划允许保险计划立即获取透析索赔中的医疗保险节省费用，而无需等待通常所需的三十个月协调期。

Clients realize up to $100K per case per month. With this acquisition, ClaimsBridge clients gain direct access to the specialized, patented solution for one of the highest-cost chronic conditions, alongside ClaimsBridge's existing cost management solutions..

客户每个案例每月可实现高达10万美元的收益。通过此次收购，ClaimsBridge的客户在享有ClaimsBridge现有成本管理解决方案的同时，还能直接获得针对最高成本慢性病症之一的专业专利解决方案。

'This is an important moment for ClaimsBridge,'

“这是ClaimsBridge的重要时刻，”

said Kevin Gibson, CEO of ClaimsBridge

ClaimsBridge 首席执行官凯文·吉布森表示

. 'Eir's investment gives us the ability to accelerate innovation for our clients and the payer market, and DialysisPPO is the strongest solution we've seen for one of healthcare's most complex and expensive conditions. Together, these moves reflect where we're headed: simplifying complexity and taking cost out of the healthcare system.'.

“Eir 的投资使我们能够加速为客户和支付方市场进行创新，而 DialysisPPO 是我们所见过的针对医疗保健领域最复杂且成本高昂的疾病之一的最强解决方案。这些举措共同反映了我们的发展方向：简化复杂性，降低医疗系统的成本。”

'ClaimsBridge sits at the pre-adjudication control point where pricing and routing decisions get made, and it solves complexity for clients without adding more of it. Our investment is about scaling that platform faster, organically and through acquisitions like DialysisPPO,'

“ClaimsBridge 位于预裁决控制点，即定价和路由决策制定的关键环节，它在帮助客户解决复杂问题的同时，并未增加额外的复杂性。我们的投资旨在加速该平台的扩展，既通过有机增长，也通过诸如收购 DialysisPPO 等并购方式实现。”

said Brett Carlson, CEO and Founder of Eir Partners.

Eir Partners 首席执行官兼创始人布雷特·卡尔森表示。

'Joining ClaimsBridge allows us to bring our ESRD savings program to a much broader base of payers, backed by ClaimsBridge's technology, network reach, and client service model.

“加入 ClaimsBridge 使我们能够借助其技术、网络覆盖范围及客户服务模式，将我们的终末期肾病（ESRD）节省计划推广至更广泛的支付方群体。”

Just as important, our existing clients now gain access to a full suite of proven cost management solutions alongside the program they already rely on

同样重要的是，我们现有的客户现在可以在他们已经依赖的项目之外，获得一整套经过验证的成本管理解决方案。

.' said John Brophy the CEO and Founder of DialysisPPO.

DialysisPPO 的首席执行官兼创始人约翰·布罗菲表示。

About ClaimsBridge

关于 ClaimsBridge

ClaimsBridge is transforming the claims lifecycle with an end-to-end ecosystem of technology solutions, along with custom network and repricing services, that reduce costs, increase accuracy, and simplify complexity for payers. Learn more at

ClaimsBridge 正通过端到端的技术解决方案生态系统，以及定制化的网络和重新定价服务，变革理赔生命周期，帮助支付方降低成本、提高准确性并简化复杂性。了解更多请访问

claimsbridge.com

claimsbridge.com

.

。

About Eir Partners

关于 Eir Partners

Eir Partners Capital is a Miami-based private equity firm focused exclusively on healthcare technology and tech-enabled services. The firm pairs operational expertise with a bottoms-up sourcing approach to accelerate value creation, and has completed transactions across the payor, provider, employer, and pharma technology sectors.

Eir Partners Capital 是一家总部位于迈阿密的私募股权公司，专注于医疗保健技术和科技赋能服务。该公司将运营专长与自下而上的项目 sourcing 方法相结合，以加速价值创造，并已完成涵盖支付方、提供方、雇主和制药技术领域的多项交易。

Learn more at .

了解更多，请访问。

eirpartners.com

eirpartners.com

.

。

About DialysisPPO

关于 DialysisPPO

DialysisPPO provides a patented cost containment solution for End-Stage Renal Disease (ESRD) and chronic dialysis treatment. The program helps payers capture Medicare coordination savings immediately for expansive savings. Learn more at

DialysisPPO 为终末期肾病（ESRD）和慢性透析治疗提供了一项专利的成本控制解决方案。该计划帮助支付方立即实现与医疗保险的协调储蓄，从而获得大幅节省。了解更多详情，请访问

dialysisppo.com

透析ppo.com

.

。

SOURCE Claimsbridge

来源 Claimsbridge

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

请求演示